Skip to main content
. 2021 Apr 27;22(9):4546. doi: 10.3390/ijms22094546

Table 2.

List of reported USP inhibitors.

Target Compound ID PDB Refs
USP inhibitors in clinical trials
USP14/UCHL5 b-AP15 None [103]
VLX1570 None [109]
USP inhibitors of reported new chemical entities
USP1 Pimozide None [113]
GW7647 None
Trifluoperazine None
Rottlerin None
C527 None [114]
SJB2-043 None
SJB3-091A None
ML323 None [115,116]
USP2 Q29 None [117]
ML364 None [118]
LCAHA None [119]
STD1T None [120]
6TG 5XU8 [121]
USP2/4/5/7/8/15/20/28/47/UCHL1/UCHL3/UCHL5 PR619 None [122,123]
USP2/5/8/UCHL1/UCHL3 AM416 None [124]
RA9 None
RA14 None
USP2/7 NSC632839 None [98]
Compound 14 None [125]
USP4/5 Vialinin A None [126]
USP5/7/8/13/14/15/22 Curcusone D None [127]
USP5/9X/14/24/UCHL5 WP1130 (Degrasny) None [128,129,130,131]
EOAI3402143 (G9) None [132]
USP7 HBX-41108 None [133]
HBX-19818 None [134]
HBX-28258 None
Spongiacidin A None [135]
GEN-6640 5UQV [136]
GEN-6776 5UQX
XL188 5V6S [137]
ALM2 5N9R [138]
ALM45 6F5H [139]
FT671 5NGE [140,141]
FT827 5NGF
Compound 2 5WHC [142]
Compound 28 None
Parthenolide (PTL) None [143]
Costunolide None
α-santonin None
USP7/8 HY50736 None [144]
HY50737A None
USP7/10 Compound 3 None [145]
Compound 9 None
USP7/47 P22077 None [122,146,147]
P5091 None [148,149,150]
P50429 None [151]
USP10/13 Spautin-1 None [152]
USP11/15 Mitoxantrone 6GH9 [153,154]
USP14 IU1 6IIK [155]
IU1-47 6IIL [156,157]
IU1-206 6IIM [157]
IU1-248 6IIN [157]
USP14/UCHL5 Auranofin None [158,159]
CuPT None [160,161]
PtPT None [162]
NiPT None [163]
USP25/28 AZ1 None [164]
USP30 MF-094 None [165]
15-oxospiramilactone (S3) None [166]